| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Departments of Environmental Health Sciences (MVG, JRP, VI, VS, FP, and JHG), Biostatistics (XL and DL), and Epidemiology (HA, YC, and PF-L), Mailman School of Public Health, Columbia University, New York, NY, and the Department of Pharmacology, College of Physicians and Surgeons (JHG), Columbia University, New York, NY
Background: Populations in South and East Asia and many other regions of the world are chronically exposed to arsenic-contaminated drinking water. To various degrees, ingested inorganic arsenic (InAs) is methylated to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) via folate-dependent one-carbon metabolism; impaired methylation is associated with adverse health outcomes. Consequently, folate nutritional status may influence arsenic methylation and toxicity.
Objective: The objective of this study was to test the hypothesis that folic acid supplementation of arsenic-exposed adults would increase arsenic methylation.
Design: Two hundred adults in a rural region of Bangladesh, previously found to have low plasma concentrations of folate (
9 nmol/L) were enrolled in a randomized, double-blind, placebo-controlled folic acid–supplementation trial. Plasma concentrations of folate and homocysteine and urinary concentrations of arsenic metabolites were analyzed at baseline and after 12 wk of supplementation with folic acid at a dose of 400 µg/d or placebo.
Results: The increase in the proportion of total urinary arsenic excreted as DMA in the folic acid group (72% before and 79% after supplementation) was significantly (P < 0.0001) greater than that in the placebo group, as was the reduction in the proportions of total urinary arsenic excreted as MMA (13% and 10%, respectively; P < 0.0001) and as InAs (15% and 11%, respectively; P < 0.001).
Conclusions: These data indicate that folic acid supplementation to participants with low plasma folate enhances arsenic methylation. Because persons whose urine contains low proportions of DMA and high proportions of MMA and InAs have been reported to be at greater risk of skin and bladder cancers and peripheral vascular disease, these results suggest that folic acid supplementation may reduce the risk of arsenic-related health outcomes.
Key Words: Folate • folic acid • folate deficiency • vitamin B-12 • homocysteine • hyperhomocysteinemia • one-carbon metabolism • S-adenosylmethionine • creatine • creatinine • arsenic • Bangladesh • monomethylarsonic acid • dimethylarsinic acid
This article has been cited by other articles:
|
|
 |
|
  M. E. Vahter Interactions between Arsenic-Induced Toxicity and Nutrition in Early Life J. Nutr., December 1, 2007; 137(12): 2798 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J R. Pilsner, X. Liu, H. Ahsan, V. Ilievski, V. Slavkovich, D. Levy, P. Factor-Litvak, J. H Graziano, and M. V Gamble Genomic methylation of peripheral blood leukocyte DNA: influences of arsenic and folate in Bangladeshi adults Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1179 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V Gamble, X. Liu, V. Slavkovich, J R. Pilsner, V. Ilievski, P. Factor-Litvak, D. Levy, S. Alam, M. Islam, F. Parvez, et al. Folic acid supplementation lowers blood arsenic Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1202 - 1209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ahsan, Y. Chen, M. G. Kibriya, V. Slavkovich, F. Parvez, F. Jasmine, M. V. Gamble, and J. H. Graziano Arsenic Metabolism, Genetic Susceptibility, and Risk of Premalignant Skin Lesions in Bangladesh Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1270 - 1278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E Heck, M. V Gamble, Y. Chen, J. H Graziano, V. Slavkovich, F. Parvez, J. A Baron, G. R Howe, and H. Ahsan Consumption of folate-related nutrients and metabolism of arsenic in Bangladesh Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1367 - 1374. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
